Molecular effects of paclitaxel-elacridar nanoemulsions in breast cancer cells: impact on uptake, cell cycle and signaling pathways (2025)
- Authors:
- USP affiliated authors: LOPES, LUCIANA BIAGINI - ICB ; MACHADO NETO, JOÃO AGOSTINHO - ICB ; SALATA, GIOVANNA CASSONE - ICB ; MALAGÓ, ISABELLA DRASZESSKI - ICB ; MELO, GIOVANNA BARROS DE - ICB
- Unidade: ICB
- DOI: 10.1016/j.ejpb.2025.114837
- Subjects: FARMACOLOGIA; ANTINEOPLÁSICOS; APOPTOSE; NEOPLASIAS MAMÁRIAS; CICLO CELULAR; ENDOCITOSE; NANOPARTÍCULAS; TRANSDUÇÃO DE SINAL CELULAR; MICROTÚBULOS; CÉLULAS CULTIVADAS DE TUMOR
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: European Journal of Pharmaceutics and Biopharmaceutics
- ISSN: 1873-3441
- Volume/Número/Paginação/Ano: v. 215, art. 114837, 9 p., 2025
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
SALATA, Giovanna Cassone et al. Molecular effects of paclitaxel-elacridar nanoemulsions in breast cancer cells: impact on uptake, cell cycle and signaling pathways. European Journal of Pharmaceutics and Biopharmaceutics, v. 215, p. 9 , 2025Tradução . . Disponível em: https://doi.org/10.1016/j.ejpb.2025.114837. Acesso em: 27 dez. 2025. -
APA
Salata, G. C., Malagó, I. D., Melo, G. B. de, Machado Neto, J. A., & Lopes, L. B. (2025). Molecular effects of paclitaxel-elacridar nanoemulsions in breast cancer cells: impact on uptake, cell cycle and signaling pathways. European Journal of Pharmaceutics and Biopharmaceutics, 215, 9 . doi:10.1016/j.ejpb.2025.114837 -
NLM
Salata GC, Malagó ID, Melo GB de, Machado Neto JA, Lopes LB. Molecular effects of paclitaxel-elacridar nanoemulsions in breast cancer cells: impact on uptake, cell cycle and signaling pathways [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2025 ; 215 9 .[citado 2025 dez. 27 ] Available from: https://doi.org/10.1016/j.ejpb.2025.114837 -
Vancouver
Salata GC, Malagó ID, Melo GB de, Machado Neto JA, Lopes LB. Molecular effects of paclitaxel-elacridar nanoemulsions in breast cancer cells: impact on uptake, cell cycle and signaling pathways [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2025 ; 215 9 .[citado 2025 dez. 27 ] Available from: https://doi.org/10.1016/j.ejpb.2025.114837 - A lipid-based in situ-forming hexagonal phase for prolonged retention and drug release in the breast tissue
- Monoolein-based nanodispersions for cutaneous co-delivery of methylene blue and metformin: thermal and structural characterization and effects on the cutaneous barrier, skin penetration and cytotoxicity
- Phosphatidylcholine-based nanoemulsions for paclitaxel and a P-Glycoprotein inhibitor delivery and breast cancer intraductal treatment
- Contributions of nanotechnology to the intraductal drug delivery for local treatment and prevention of breast cancer
- In vitro methodologies to evaluate nanocarriers for cancer treatment: where are we?
- Microemulsion for prolonged release of fenretinide in the mammary tissue and prevention of breast cancer development
- Rethinking breast cancer chemoprevention: technological advantages and enhanced performance of a Nanoethosomal-Based Hydrogel for topical administration of Fenretinide
- Optimization of nanoemulsified systems containing lamellar phases for co-delivery of celecoxib and endoxifen to the skin aiming for breast cancer chemoprevention and treatment
- Sistemas biorresponsivos para liberação sustentada de fármacos visando a quimioprevenção do câncer de mama
- Abrindo a caixa de pandora dos nanomedicamentos: há realmente muito mais ‘espaço lá embaixo’
Informações sobre o DOI: 10.1016/j.ejpb.2025.114837 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
